Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisarg Joshi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncology Letters|October 30, 2020
Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of the head and neck: A multicenter retrospective studySaroj Kumar Das Majumdar, Sundaram Subramanian, Ghanashyam Biswas, et al.
Molecular and Clinical Oncology|August 6, 2020
Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in gastric and gastroesophageal junction adenocarcinomaSundaram Subramanian, Saroj Kumar Das Majumdar, Ghanashyam Biswas, et al.
Breast Cancer (Dove Medical Press)|June 18, 2020
Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective StudySundaram Subramanian, Rammohan Prasanna, Ghanashyam Biswas, et al.
Sarcoma|December 13, 2019
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective StudyPrasad Narayanan, Palanki Satya Dattatreya, Rammohan Prasanna, et al.
Frontiers in Oncology|October 7, 2024
Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle EastSuyog Jain, Shaheenah Dawood, Viraj Lavingia, et al.
Oncology Letters|August 22, 2018
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancerSenthil Rajappa, Ashish Joshi, Dinesh C Doval, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter studySudeep Gupta, Ghanashyam Biswas, Suresh Babu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncology Letters|October 30, 2020
Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of the head and neck: A multicenter retrospective studySaroj Kumar Das Majumdar, Sundaram Subramanian, Ghanashyam Biswas, et al.
Molecular and Clinical Oncology|August 6, 2020
Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in gastric and gastroesophageal junction adenocarcinomaSundaram Subramanian, Saroj Kumar Das Majumdar, Ghanashyam Biswas, et al.
Breast Cancer (Dove Medical Press)|June 18, 2020
Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective StudySundaram Subramanian, Rammohan Prasanna, Ghanashyam Biswas, et al.
Sarcoma|December 13, 2019
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective StudyPrasad Narayanan, Palanki Satya Dattatreya, Rammohan Prasanna, et al.
Frontiers in Oncology|October 7, 2024
Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle EastSuyog Jain, Shaheenah Dawood, Viraj Lavingia, et al.
Oncology Letters|August 22, 2018
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancerSenthil Rajappa, Ashish Joshi, Dinesh C Doval, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter studySudeep Gupta, Ghanashyam Biswas, Suresh Babu, et al.
Pageof 2